Aclaris Therapeutics, Inc. (ACRS) Revenue 2017–2025
Aclaris Therapeutics, Inc. (ACRS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.8MFY2025 · since FY2017: $1.7M → $7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.8M | -58.2% |
| FY2024 | $18.7M | -40.1% |
| FY2023 | $31.2M | +5.0% |
| FY2022 | $29.8M | +340.1% |
| FY2021 | $6.8M | +4.3% |
| FY2020 | $6.5M | +53.3% |
| FY2019 | $4.2M | -31.3% |
| FY2018 | $6.2M | +265.5% |
| FY2017 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice